120 related articles for article (PubMed ID: 17597786)
1. Tumor necrosis factor-alpha in cisplatin nephrotoxicity: a homebred foe?
Dong Z; Atherton SS
Kidney Int; 2007 Jul; 72(1):5-7. PubMed ID: 17597786
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells.
Zhang B; Ramesh G; Norbury CC; Reeves WB
Kidney Int; 2007 Jul; 72(1):37-44. PubMed ID: 17396112
[TBL] [Abstract][Full Text] [Related]
3. TNF-α-mediated NF-κB survival signaling impairment by cisplatin enhances JNK activation allowing synergistic apoptosis of renal proximal tubular cells.
Benedetti G; Fredriksson L; Herpers B; Meerman J; van de Water B; de Graauw M
Biochem Pharmacol; 2013 Jan; 85(2):274-86. PubMed ID: 23103562
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition of NADPH oxidase protects against cisplatin induced nephrotoxicity in mice by two step mechanism.
Wang Y; Luo X; Pan H; Huang W; Wang X; Wen H; Shen K; Jin B
Food Chem Toxicol; 2015 Sep; 83():251-60. PubMed ID: 26032634
[TBL] [Abstract][Full Text] [Related]
5. Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-alpha.
Ramesh G; Reeves WB
Kidney Int; 2004 Feb; 65(2):490-9. PubMed ID: 14717919
[TBL] [Abstract][Full Text] [Related]
6. PPAR-α Deletion Attenuates Cisplatin Nephrotoxicity by Modulating Renal Organic Transporters MATE-1 and OCT-2.
Freitas-Lima LC; Budu A; Arruda AC; Perilhão MS; Barrera-Chimal J; Araujo RC; Estrela GR
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049997
[TBL] [Abstract][Full Text] [Related]
7. TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure.
Ramesh G; Reeves WB
Am J Physiol Renal Physiol; 2003 Oct; 285(4):F610-8. PubMed ID: 12865254
[TBL] [Abstract][Full Text] [Related]
8. Rutin attenuates cisplatin induced renal inflammation and apoptosis by reducing NFκB, TNF-α and caspase-3 expression in wistar rats.
Arjumand W; Seth A; Sultana S
Food Chem Toxicol; 2011 Sep; 49(9):2013-21. PubMed ID: 21605616
[TBL] [Abstract][Full Text] [Related]
9. [Incidence, risk factors and prevention of cisplatin-induced nephrotoxicity in patients with lung cancer].
Losonczy G; Máthé C; Müller V; Szondy K; Moldvay J
Magy Onkol; 2010 Dec; 54(4):289-96. PubMed ID: 21163759
[TBL] [Abstract][Full Text] [Related]
10. Cancer therapy and renal injury.
Schrier RW
J Clin Invest; 2002 Sep; 110(6):743-5. PubMed ID: 12235103
[No Abstract] [Full Text] [Related]
11. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity.
Ramesh G; Reeves WB
J Clin Invest; 2002 Sep; 110(6):835-42. PubMed ID: 12235115
[TBL] [Abstract][Full Text] [Related]
12. Role of the TNF pathway in the progression of diabetic nephropathy in KK-A(y) mice.
Omote K; Gohda T; Murakoshi M; Sasaki Y; Kazuno S; Fujimura T; Ishizaka M; Sonoda Y; Tomino Y
Am J Physiol Renal Physiol; 2014 Jun; 306(11):F1335-47. PubMed ID: 24647715
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin-induced renal toxicity via tumor necrosis factor-α, interleukin 6, tumor suppressor P53, DNA damage, xanthine oxidase, histological changes, oxidative stress and nitric oxide in rats: protective effect of ginseng.
Yousef MI; Hussien HM
Food Chem Toxicol; 2015 Apr; 78():17-25. PubMed ID: 25640527
[TBL] [Abstract][Full Text] [Related]
14. Telmisartan ameliorates cisplatin-induced nephrotoxicity by inhibiting MAPK mediated inflammation and apoptosis.
Malik S; Suchal K; Gamad N; Dinda AK; Arya DS; Bhatia J
Eur J Pharmacol; 2015 Feb; 748():54-60. PubMed ID: 25510231
[TBL] [Abstract][Full Text] [Related]
15. Kinin B2 receptor deletion and blockage ameliorates cisplatin-induced acute renal injury.
Estrela GR; Wasinski F; Bacurau RF; Malheiros DM; Câmara NO; Araújo RC
Int Immunopharmacol; 2014 Sep; 22(1):115-9. PubMed ID: 24975837
[TBL] [Abstract][Full Text] [Related]
16. The small-molecule TNF-alpha modulator, UTL-5g, reduces side effects induced by cisplatin and enhances the therapeutic effect of cisplatin in vivo.
Shaw J; Chen B; Huang WH; Lee AR; Media J; Valeriote FA
J Exp Ther Oncol; 2011; 9(2):129-37. PubMed ID: 21699020
[TBL] [Abstract][Full Text] [Related]
17. The pathological role of Bax in cisplatin nephrotoxicity.
Wei Q; Dong G; Franklin J; Dong Z
Kidney Int; 2007 Jul; 72(1):53-62. PubMed ID: 17410096
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin nephrotoxicity.
Arany I; Safirstein RL
Semin Nephrol; 2003 Sep; 23(5):460-4. PubMed ID: 13680535
[TBL] [Abstract][Full Text] [Related]
19. MEK inhibitor, U0126, attenuates cisplatin-induced renal injury by decreasing inflammation and apoptosis.
Jo SK; Cho WY; Sung SA; Kim HK; Won NH
Kidney Int; 2005 Feb; 67(2):458-66. PubMed ID: 15673293
[TBL] [Abstract][Full Text] [Related]
20. Sirtuin 7 Deficiency Ameliorates Cisplatin-induced Acute Kidney Injury Through Regulation of the Inflammatory Response.
Miyasato Y; Yoshizawa T; Sato Y; Nakagawa T; Miyasato Y; Kakizoe Y; Kuwabara T; Adachi M; Ianni A; Braun T; Komohara Y; Mukoyama M; Yamagata K
Sci Rep; 2018 Apr; 8(1):5927. PubMed ID: 29651144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
